Skip to main content

Table 1 Characteristics of included guidelines and eligible outcome studies

From: Protocols for uncontrolled donation after circulatory death: a systematic review of international guidelines, practices and transplant outcomes

Guidelines (n = 6)

National/Regional Guideline Country; region (year)

Language

Population targeted

Location of cardiac arrest

Organ(s)

FRANCE (2007) [30]

French

Adult

Out of hospital and in hospital

Kidney and liver

ITALY; Pavia (2011) [34]

English

Adult and children (≥15 years)

Out of hospital and in hospital

Kidney

SWITZERLAND (2011) [32]

French

Adult and children (≥16 years)

Out of hospital and in hospital

Kidney

US; New York City (2011) [4]

English

Adult and children

Out of hospital

Kidney and

liver (phased in)

SPAIN [31];

    

Alicante (2012)

Spanish

Adult and children (≥14 years)

Out of hospital

Kidney, liver, and lung

Barcelona (2012)

Adult and children (≥14 years)

Kidney and liver

Castilla La Mancha (2012)

Adult and children (≥7 years)

Kidney, liver, and lung

Granada (2012)

Adult and children (≥7 years)

Kidney, liver, and lung

Galicia (2012)

Adult and children (≥14 years)

Kidney and liver

Madrid City and Region (2012)

Adult and children

Kidney, liver, and lung

UK; Scotland (2013) [33]

English

Adult and children (≥16 years)

Out of hospital

Kidney, Liver and lungs

Eligible outcome studies (n = 18)

Study/Country, Region

Study design

Population studied

Location of cardiac arrest

Organ(s)

Gámez 2005 [13]/Spain, Madrid

Case series

Adult

Out of hospital

Lung

Gagandeep 2006 [14]/USA, Nationwide

Database review comparison to DBD and cDCD

Adult and children

in hospital

Kidney

Sánchez-Fructuoso 2006 [15]/Spain, Madrid

Retrospective cohort

Adult

Out of hospital and in hospital

Kidney

Fondevila 2007 [16]/Spain, Barcelona

Retrospective cohort with Matched DBD controls

Age not specified

Out of hospital

Liver

Suárez 2008 [17]/Spain, La Coruna

Retrospective cohort compared to HBD

Adult

Out of hospital and in hospital

Liver

Fieux 2009 [18]/France, Paris

Prospective cohort

Adult

Out of hospital

Kidney

Gómez Gutiérrez 2009 [19]/Spain, La Coruña and Madrid

Case series

Adult

Out of hospital

Liver

Jiménez-Galanes 2009 [20]/Spain, Madrid

Prospective case Control matched to DBD

Adult

Out of hospital

Liver

Ribalta 2009 [29]/Spain, Cataluña

Retrospective cohort

Adult and children

Out of hospital

Kidney and liver

Mateos-Rodríguez 2010 [21]/Spain, Madrid

Retrospective cohort

Adult and children

Out of hospital

Kidney, liver, and lungs

Mateos-Rodríguez 2010 [22]/Spain, Madrid

Retrospective cohort

Adult

Out of hospital

Kidney

Geraci and Sepe 2011 [34]/Italy, Pavia

Retrospective Cohort

Adult

In hospital

Kidney

Hoogland 2011 [23]/The Netherlands, Maastricht

Retrospective cohort compared with cDCD

Adult

Out of hospital

Kidney

Rodríguez 2011 [24]/Spain, Madrid and Santander

Retrospective cohort

Adult and children

Out of hospital

Lungs

Fondevila 2012 [25]/Spain, Barcelona

Retrospective cohort

Adult

Out of Hospital

Liver

Gómez-de-Antonio 2012 [26]/Spain, Madrid

Prospective cohort

Adult

Out of hospital

Lung

Hanf 2012 [27]/France, Lyon

Prospective cohort compared with ECD and SPK

Adult

Out of hospital

Kidney

Reznick 2013 [28]/Russia, St Petersburg

Retrospective cohort

Adult

In hospital

Kidney

  1. Extended criteria donors (ECDs) were all donors at least 60 years old and those 50–59 years old with at least two of the other three conditions (cerebrovascular cause of death, renal insufficiency with serum creatinine less than or equal to 1.5 mg/dl, and hypertension)
  2. DBD donation after brain death, cDCD controlled donation after circulatory death, HBD heart beating donors, SPK simultaneous non-sensitized kidney pancreas transplanted patients that received kidneys from optimal donors
  3. Please note that the article by Geraci and Sepe (2011) was included in both the “Guidelines” and “Eligible outcome studies” sections of this table because it included both a guideline for a protocol and its preliminary results